From Medscape Neurology

Coverage from the

American Academy of Neurology (AAN) 2025 Annual Meeting

April 05 - 09, 2025; San Diego, California

April 05 - 09, 2025 San Diego, California

Conference News

AAN 2025 Novel Agent for AD Agitation Continues to Show Promise
Medscape Medical News, April 11, 2025
AAN 2025 Prenatal Folic Acid May Boost Brain Health in Offspring
Medscape Medical News, April 11, 2025
AAN 2025 AI-Powered Wearable Calms Essential Tremor
Medscape Medical News, April 10, 2025
AAN 2025 Inebilizumab Effective Up to 52 Weeks in Myasthenia Gravis
Medscape Medical News, April 10, 2025
AAN 2025 First-in-Class Digital Therapeutic Effective for Migraine
Medscape Medical News, April 9, 2025
AAN 2025 Transnasal Cooling Promising for Migraine
Medscape Medical News, April 8, 2025

AAN 2025 Frequent Nightmares Linked to Faster Aging, Premature Death
Medscape Medical News, April 8, 2025
AAN 2025 OTC Analgesics Improve Concussion Outcomes
Medscape Medical News, March 13, 2025
AAN 2025 A New Option for Intractable Pediatric Migraine?
Medscape Medical News, March 10, 2025
AAN 2025 CPAP for Sleep Apnea May Lower Risk for Parkinson’s Disease
Medscape Medical News, March 10, 2025
AAN 2025 Simple Algorithm Reduces Racial Disparities in MS
Medscape Medical News, March 10, 2025
AAN 2025 Marine Microplastics Linked to Neurologic Dysfunction
Medscape Medical News, March 7, 2025

Medscape Neurology©

Popular News From AAN 2024

Novel Agent Curbs Alzheimer's-Related Agitation AXS-05, a combination of dextromethorphan and bupropion, led to a rapid and sustained improvement in agitation related to Alzheimer's disease in the phase 3 ACCORD trial.
Medscape Medical News, Apr 23, 2024
Tension, Other Headache Types Robustly Linked to Suicide Headache, including tension-type, migraine, and posttraumatic, are robustly associated with both attempted and completed suicide, a large study shows.
Medscape Medical News, Apr 16, 2024
Vaporized Cannabis for Acute Migraine Yields Rapid Relief In the first randomized controlled trial, vaporized cannabis containing a THC-CBD mix led to rapid and sustained relief of acute migraine.
Medscape Medical News, Apr 17, 2024

Previous Coverage

Related Resources

All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.